Hypothyroidism in Older Adults: TSH Targets, Drug Sensitivity, and Cognition

TSH naturally rises with age; targets in older adults are higher (often 1.0 to 4.5 mIU/L over 70). When levothyroxine is needed, start low and go slow due to cardiac sensitivity. Over-replacement raises atrial fibrillation and fracture risk. The TRUST and IEMO80 trials showed no benefit of treating subclinical hypothyroidism in adults over 65.

Why TSH targets shift with age

TSH is not a fixed number across the lifespan. Large population datasets show the median TSH drifts upward by roughly 0.3 to 0.5 mIU/L per decade after age 60, and the 97.5th percentile in healthy adults over 80 reaches 6 to 7 mIU/L [C5]. This is not "disease creep" — it is the normal pituitary–thyroid set point of an older body, and treating to a young-adult range over-medicates a substantial share of older patients [C5].

Two physiologic changes drive most of the difference [C5][C8]:

• Reduced peripheral T4-to-T3 conversion, which the pituitary partially compensates for by raising TSH.
• A blunted feedback loop, so a given level of T4 produces slightly more TSH than it did at age 30.

The clinical consequence: a 75-year-old with a TSH of 5.8 mIU/L and a normal free T4 is usually not hypothyroid in any clinically meaningful sense [C2][C5]. Treating that number to "0.5 to 2.5" — a range derived from younger cohorts — pushes many patients into iatrogenic subclinical hyperthyroidism.

What the major trials actually show

Two large randomized trials specifically tested whether treating subclinical hypothyroidism in older adults improves outcomes [C2][C3].

TRUST (Stott et al., NEJM 2017). 737 adults aged 65 and older with persistent subclinical hypothyroidism (mean TSH ~6.4 mIU/L) were randomized to levothyroxine (titrated to a normal TSH) or placebo for 1 year. There was no difference in hypothyroid symptom scores, tiredness scores, blood pressure, weight, or quality of life. TSH normalized in the treatment arm — symptoms did not change [C2].

IEMO80 (Mooijaart et al., JAMA 2019). A follow-on trial focused on adults aged 80 and older — the group most often pushed toward treatment. 251 participants randomized to levothyroxine versus placebo. Again, no benefit on thyroid-related symptoms or tiredness [C3].

A 2026 systematic review pooled the entire literature on levothyroxine for subclinical hypothyroidism in older adults and confirmed the same pattern: no measurable benefit on quality of life or cardiovascular endpoints [C4].

The bottom line of this evidence is that mildly elevated TSH in an older adult — TSH between 4.5 and 10 mIU/L with normal free T4 — is rarely a treat-to-treat condition [C2][C3][C4].

How dosing differs in older adults

When overt hypothyroidism is present (free T4 below normal, or TSH greater than 10 mIU/L with symptoms), older adults do need replacement — but dosing diverges from the young-adult playbook [C1][C8]:

• Lower starting dose. ATA recommends 25 to 50 mcg daily as the typical starting dose in patients over 60 or with known cardiac disease, versus full weight-based dosing (~1.6 mcg/kg) in healthy younger adults [C1].
• Slower titration. Increase by 12.5 to 25 mcg every 6 to 8 weeks rather than every 4 [C1].
• Higher TSH target. Many endocrinologists aim for TSH 1.0 to 4.5 mIU/L (or even up to 6.0 over age 80) rather than the 0.5 to 2.5 typical of younger patients [C1][C5].

The reason is cardiac. Older hearts tolerate thyroid hormone less well; a dose increase that a 35-year-old would not notice can precipitate angina, palpitations, or atrial fibrillation in a 75-year-old [C1][C6].

Drug interactions that matter most in older adults

Older patients accumulate medications, and several interact significantly with levothyroxine [C1][C7]:

1. Amiodarone. Contains roughly 75 mg of iodine per 200 mg tablet — about 250 times the daily requirement. It can trigger amiodarone-induced thyrotoxicosis or hypothyroidism and confounds TSH interpretation for months after stopping [C1].
2. Proton pump inhibitors (PPIs). Used chronically by ~30% of adults over 70. They raise gastric pH and reduce levothyroxine absorption 20 to 30% [C1]. See our proton-pump-inhibitors-levothyroxine article.
3. Calcium and iron supplements. Bind levothyroxine in the gut; must be separated by at least 4 hours [C1].
4. Bile acid sequestrants (cholestyramine, colesevelam). Strongly impair absorption; separate by 4 hours minimum [C1].
5. Beta blockers. Not a true interaction, but they blunt the cardiac symptoms of over-replacement, which can mask under-dosing of the levothyroxine itself.

Cognition: does levothyroxine help?

This is one of the most-asked questions and one of the clearest answers in the literature: no reliable cognitive benefit from treating subclinical hypothyroidism in older adults [C2][C3][C4]. The TRUST and IEMO80 trials both measured cognitive endpoints and found no difference. The 2026 systematic review reached the same conclusion [C4].

This does not mean overt hypothyroidism is harmless to cognition — severe untreated hypothyroidism (myxedema) clearly impairs cognition and reverses with treatment [C1]. But in the much larger population of older adults with mildly elevated TSH and intact free T4, levothyroxine is not a cognitive intervention.

What does NOT help

• "Optimizing" TSH below 1.0 mIU/L in older adults — pushes into subclinical hyperthyroidism range and raises atrial fibrillation risk by 30 to 40% in this age group [C6][C7].
• Adding T3 (liothyronine) routinely for cognition or fatigue in older patients — no trial evidence and increases cardiac sensitivity [C1].
• Treating an isolated TSH of 5 to 7 mIU/L in an asymptomatic person over 70. The TRUST/IEMO80 evidence argues against it [C2][C3][C4].
• Desiccated thyroid (NDT) without a specific indication. ATA recommends levothyroxine as first-line, and NDT carries a less predictable T3/T4 ratio that older hearts tolerate poorly [C1].

Practical guidelines

1. Know your age-appropriate TSH range. Ask your endocrinologist what range they're targeting for your age — for many adults over 70, a TSH between 1.0 and 4.5 mIU/L (or up to 6.0 over 80) is acceptable [C1][C5].
2. If levothyroxine is started, expect a low starting dose — typically 25 to 50 mcg, not full weight-based dosing [C1].
3. Recheck TSH at 6 to 8 weeks after any dose change, not 4 [C1].
4. Avoid TSH suppression below 0.5 mIU/L. Over-replacement raises atrial fibrillation and fracture risk substantially in this age group [C6][C7].
5. Tell your prescriber about every supplement. Calcium, iron, PPIs, and bile acid resins all interfere with absorption [C1].
6. If amiodarone is on the medication list, get thyroid function checked before starting and every 6 months thereafter [C1].

Frequently asked questions

Why is my TSH 5.5 and my doctor isn't treating it? Because in older adults a TSH between 4.5 and 10 mIU/L with normal free T4 is most often a normal age-adjusted value, not a disease state — and two large randomized trials (TRUST and IEMO80) showed no benefit from treating it [C2][C3][C4].

Will levothyroxine help my memory? In overt hypothyroidism, yes — cognitive function recovers as TSH normalizes [C1]. In subclinical hypothyroidism (mildly elevated TSH, normal free T4), trial evidence shows no measurable cognitive benefit [C2][C3][C4].

Why does my heart race when my dose is increased? Older hearts are more sensitive to thyroid hormone. Even small dose increases can trigger palpitations, angina, or atrial fibrillation. Your endocrinologist will typically titrate by 12.5 to 25 mcg every 6 to 8 weeks rather than the larger jumps used in younger patients [C1][C6].

Is desiccated thyroid better for older adults? No. NDT contains a fixed T3/T4 ratio with a sharp T3 peak that older hearts tolerate less well than the steady T4 release from levothyroxine [C1]. The ATA continues to recommend levothyroxine as first-line.

Does treating subclinical hypothyroidism prevent heart disease in older adults? The TRUST trial and the 2026 systematic review both measured cardiovascular endpoints. No benefit was seen on cardiovascular events or quality of life [C2][C4].

Bottom line

TSH rises naturally with age, and the reference ranges that apply to younger adults over-medicate older ones [C5]. Two large randomized trials (TRUST and IEMO80) and a 2026 systematic review all converge on the same conclusion: treating subclinical hypothyroidism in adults over 65 does not improve symptoms, quality of life, or cognition [C2][C3][C4]. When levothyroxine is genuinely needed for overt hypothyroidism, older adults need a lower starting dose, slower titration, and a higher TSH target — and the cost of over-replacement (atrial fibrillation, fractures) is real [C1][C6][C7]. Talk to your endocrinologist about what range is right for your age.

Sources

1. [C1] Jonklaas J, Bianco AC, Bauer AJ, et al. Guidelines for the treatment of hypothyroidism. Thyroid. 2014;24(12):1670–1751. PubMed: 25266247
2. [C2] Stott DJ, Rodondi N, Kearney PM, et al. Thyroid Hormone Therapy for Older Adults with Subclinical Hypothyroidism. N Engl J Med. 2017;376(26):2534–2544. PubMed: 28402245
3. [C3] Mooijaart SP, Du Puy RS, Stott DJ, et al. Association Between Levothyroxine Treatment and Thyroid-Related Symptoms Among Adults Aged 80 Years and Older With Subclinical Hypothyroidism. JAMA. 2019;322(20):1977–1986. PubMed: 31664429
4. [C4] Tuesta-Nole JR et al. Levothyroxine for subclinical hypothyroidism in older adults: no evidence of benefit on quality of life or cardiovascular outcomes: a systematic review. 2026. PubMed: 41922998
5. [C5] Surks MI, Ortiz E, Daniels GH, et al. Subclinical thyroid disease: scientific review and guidelines for diagnosis and management. JAMA. 2004;291(2):228–238. PubMed: 14722150
6. [C6] Selmer C, Olesen JB, Hansen ML, et al. The spectrum of thyroid disease and risk of new onset atrial fibrillation: a large population cohort study. BMJ. 2012;345:e7895. PubMed: 23186910
7. [C7] Baskaran BS et al. Risk of cardiac, neuropsychiatric and musculoskeletal adverse events with levothyroxine: Systematic review. 2026. PubMed: 41559017
8. [C8] American Thyroid Association. Hypothyroidism — Patient Information. thyroid.org

---

For educational purposes only. Not medical advice. Always consult your healthcare provider.